000 | 01014 a2200289 4500 | ||
---|---|---|---|
005 | 20250514014756.0 | ||
264 | 0 | _c20020408 | |
008 | 200204s 0 0 eng d | ||
022 | _a1089-3261 | ||
024 | 7 |
_a10.1016/s1089-3261(05)70208-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCotler, S J | |
245 | 0 | 0 |
_aTreatment of hepatitis C virus and HIV co-infections. _h[electronic resource] |
260 |
_bClinics in liver disease _cNov 2001 |
||
300 |
_a1045-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferons _xtherapeutic use |
650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJensen, D M | |
773 | 0 |
_tClinics in liver disease _gvol. 5 _gno. 4 _gp. 1045-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1089-3261(05)70208-7 _zAvailable from publisher's website |
999 |
_c11602541 _d11602541 |